Table 3

Baseline characteristics by treatment assignment

Treatment group
Mean age, years (SD)67 (11)59 (14)
Men (%)6467
Caucasian (%)9178
Weight, kg (SD)86 (19)92 (22)
Body mass index, kg/m2 (SD)30 (6)31 (6)
Waist circumference (cm)110 (11)101 (18)
Smoking status (%)
Primary diagnosis of chronic kidney disease (%)
 Polycystic kidney disease017
Comorbidities (%)
 Coronary artery disease96
 Peripheral vascular disease276
 Gastric bleeding180
Mean blood pressure, mm Hg (SD)
 Systolic143 (17)140 (22)
 Diastolic73 (11)80 (11)
Heart rate, bpm (SD)80 (11)80 (13)
eGFR, mL/min/1.73 m2 (SD)39 (11)41 (10)
Hematocrit, L/L (SD)0.39 (0.05)0.40 (0.06)
HbA1c (SD)0.07 (0.02)0.07 (0.01)
Medications (%)
 ACE/ARB inhibitors6467
 Calcium channel blockers4622
 Beta blockers2717
 Angiotensin II receptor blockers4617
First degree relative with hypertension or kidney failure4661
  • ACE/ARB, angiotensin-converting enzyme/angiotensin receptor blockers; COPD, chronic obstructive pulmonary disorder; eGFR, estimated glomerular filtration rate; HbA1c, glycated haemoglobin; TIA, transient ischemic attack..